Anandia Labs Inc is a plant biotechnology company focused on cannabis genetics and variety development. We apply a combination of genomic and metabolite analysis to better understand the medical potential of cannabis and cannabinoid drugs, and to create cannabis varieties with improved therapeutic properties. We are also engaged in R&D towards non-plant production of cannabinoids.
Anandia Labs was co-founded by Dr. Jonathan Page, who co-led the team that published the first cannabis genome sequence and whose research program discovered many of the enzymes involved in cannabinoid production. Co-founder and COO Dr. John Coleman is a natural products chemist with more than 15 years experience in the biopharma industry. Anandia Labs is based on the UBC campus in Vancouver, Canada.